Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Assets (2016 - 2025)

Orthopediatrics has reported Assets over the past 10 years, most recently at $508.6 million for Q4 2025.

  • Quarterly results put Assets at $508.6 million for Q4 2025, up 7.49% from a year ago — trailing twelve months through Dec 2025 was $508.6 million (up 7.49% YoY), and the annual figure for FY2025 was $508.6 million, up 7.49%.
  • Assets for Q4 2025 was $508.6 million at Orthopediatrics, up from $493.5 million in the prior quarter.
  • Over the last five years, Assets for KIDS hit a ceiling of $508.6 million in Q4 2025 and a floor of $301.0 million in Q1 2022.
  • Median Assets over the past 5 years was $431.6 million (2023), compared with a mean of $412.9 million.
  • Peak annual rise in Assets hit 79.88% in 2021, while the deepest fall reached 6.34% in 2021.
  • Orthopediatrics' Assets stood at $304.3 million in 2021, then soared by 40.57% to $427.7 million in 2022, then rose by 2.58% to $438.7 million in 2023, then grew by 7.86% to $473.2 million in 2024, then rose by 7.49% to $508.6 million in 2025.
  • The last three reported values for Assets were $508.6 million (Q4 2025), $493.5 million (Q3 2025), and $503.6 million (Q2 2025) per Business Quant data.